What are the objectives for CART-meso immunotherapy?

Bookmark and Share
Published: 30 Apr 2015
Views: 2228
Dr Janos Tanyi - University of Pennsylvania, Philadelphia, USA

Dr Tanyi talks to ecancertv at AACR 2015 about how he has used mesothelin as a conjugate with the CART-cell and what the clinical objectives are for this treatment.

Read the news story for more.